HEALTHY VOLUNTEERS

212494


RSV VACCINE IN OLDER ADULTS

Study Title

Efficacy study of GSK’s investigational respiratory syncytial virus (RSV) vaccine in adults aged 60 years and above.

Study duration

2.5 – 3 years

Number of CLINIC VISITS

4 clinic visits

NUMBER OF PHONE CALLS

3 phone calls plus fortnightly or monthly contacts (via phone, SMS or email) for the study duration

Main entry criteria
  • 60 years of age or above
    • Generally healthy

    There are additional eligibility requirements to enrol in this study. Our Study Doctor will review the study requirements and discuss your eligibility with you either over the telephone or at your first clinic visit.

    Assessments
    • Vital signs
    • Gait Speed Test
    • Blood tests
    • Questionnaires
    • Nose and throat swabs

    Eligible participants will receive a vaccination at Visit 1.

    You will receive all study-related procedures, medications, and laboratory services at no cost. In addition, you will be reimbursed $50 per visit for your time and travel.

    212458


    COMBINED MENINGOCOCCAL ABCWY STUDY

    Study Title

    A study on the safety, effectiveness and immune response of meningococcal combined ABCWY vaccine in healthy adolescents and adults.

    Study duration

    7 months

    Number of CLINIC VISITS

    3 clinic visits

    Number of phone calls

    2 phone calls

    Main entry criteria
    • 18 to 50 years of age
    • Generally healthy
    • Have never received a vaccine against Meningococcal A, C, W and/or Y OR received a single vaccine dose at least 4 years ago (you can join the study if a MeningococcalC vaccine was received at or before 2 years of age)
    • Never received a vaccine against MeningococcalB

    There are additional eligibility requirements to enrol in this study. Our Study Doctor will review the study requirements and discuss your eligibility with you either over the telephone or at your first clinic visit.

    Assessments
    • Vital signs
    • Blood tests
    • Questionnaires

    Eligible participants will receive a vaccination at Visits 1 and 2. Note that all participants receive the investigational vaccine. There is no placebo in this study.

    You will receive all study-related procedures, medications, and laboratory services at no cost.  In addition, you will be reimbursed $80-130 per visit for your time and travel and $50 per phone call.

    Loading...